OverviewSuggest Edit

Cerebral is a mental health company providing treatment for anxiety and depression. It offers video visits with a prescribing provider, medication delivery if prescribed, and an assigned care manager who is available for regular check-in calls and unlimited messaging.
HQSan Francisco, CA, US
Employee Ratings3.6

Latest Updates

Employees (est.) (May 2022)1,648(+6%)
Job Openings171
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Cerebral Office Locations

Cerebral has offices in San Francisco and Walnut
San Francisco, CA, US (HQ)
555 Mission Street, 555 Mission St, San Francisco
Walnut, CA, US
340 S Lemon Ave #9892
Show all (2)

Cerebral Financials and Metrics

Summary Metrics

Founding Date


Cerebral total Funding

$162 m

Cerebral latest funding size

$127 m

Time since last funding

a year ago

Cerebral investors

Cerebral's latest funding round in June 2021 was reported to be $127 m. In total, Cerebral has raised $162 m
Show all financial metrics

Cerebral Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Cerebral Online and Social Media Presence

Embed Graph

Cerebral News and Updates

Cerebral CEO Ousted, Over One Million Covid Deaths and Liquid Biopsy For Pregnancy

InnovationRx is your weekly digest of healthcare news. Sign up!

Kyle Robertson Is Out As CEO Of Mental Health Startup Cerebral

Chief medical officer David Mou named CEO, as the company faces a DOJ investigation and lawsuit from an ex-executive over its medication prescribing practices.

Global Cerebral Palsy Treatment Market Report to 2030 - Featuring Merz Pharmaceuticals, Pfizer, Bayer and Johnson & Johnson Among Others

Dublin, May 16, 2022 (GLOBE NEWSWIRE) -- The "Cerebral Palsy Treatment Market by Drug Type, Disease Type, Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering. The global cerebral palsy treatment market was v…

Cerebral receives grand jury subpoena from U.S. attorney

The company is among a handful of startups that began prescribing controlled substances online after a regulatory rollback in connection with the COVID-19 pandemic.

InnovationRx: Cerebral Stops ADHD Prescribing; Plus, Big Sales For Covid Vaccines

InnovationRx is your weekly digest of healthcare news. Sign up!

Telehealth startup Cerebral will stop prescribing Adderall for new ADHD patients

Executives at telehealth startup Cerebral told their clinicians that the company will stop prescribing Adderall and other controlled substances to treat attention deficit hyperactivity disorder, the company announced Wednesday. Driving the news: The decision comes after Cerebral's preferred pharmacy…
Show more

Cerebral Frequently Asked Questions

  • When was Cerebral founded?

    Cerebral was founded in 2019.

  • How many employees does Cerebral have?

    Cerebral has 1,648 employees.

  • Who are Cerebral competitors?

    Competitors of Cerebral include EACH, Talkspace and Heard.

  • Where is Cerebral headquarters?

    Cerebral headquarters is located at 555 Mission Street, 555 Mission St, San Francisco, San Francisco.

  • Where are Cerebral offices?

    Cerebral has offices in San Francisco and Walnut.

  • How many offices does Cerebral have?

    Cerebral has 2 offices.